The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Mylan N.V. (NASDAQ: MYL) who purchased shares between May 9, 2018 and May 6, 2019. The action, which was filed in the United States District Court for the Western District of Pennsylvania, alleges that the Company violated federal securities laws.
In particular, the Mylan lawsuit alleges that (1) Mylan’s Morgantown facility was in significant violation of the FDA’s Current Good Manufacturing Practice regulations; (2) Mylan would need to engage in a massive restructuring and remediation program; (3) Mylan’s North American Segment would be substantially impacted by said program, which would in turn materially impact Mylan’s financial health; (3) Mylan lacked effective internal control over financial reporting; and (4) as a result of the foregoing, the Company’s financial statements were materially false and misleading at all relevant times.
Shareholders have until February 14, 2020 to petition the court for lead plaintiff status. Your ability to share in any recovery does not require that you serve as lead plaintiff. You may choose to be an absent class member.
To learn more and keep informed, complete this form >